Trevi Therapeutics Inc. (TRVI)
NASDAQ: TRVI
· Real-Time Price · USD
7.51
0.02 (0.27%)
At close: Aug 15, 2025, 3:59 PM
7.52
0.07%
After-hours: Aug 15, 2025, 04:10 PM EDT
Trevi Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 146K | n/a | n/a | n/a | 176K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 38K | 37K | n/a | 36K | 38K | 35K | 35K | 35K | 34K | 19K | 15K | 9K | 8K | 11K | 12K | 13K | 12K | 13K |
Gross Profit | -38K | -37K | 73K | -36K | -38K | -35K | 141K | -35K | -34K | -19K | -15K | -9K | -8K | -11K | -12K | -13K | -12K | -13K |
Operating Income | -13.72M | -11.47M | -12.24M | -14.09M | -13.29M | -11.91M | -8.93M | -9.04M | -8.38M | -7.56M | -6.66M | -8.4M | -7.82M | -7.03M | -8.27M | -6.95M | -9.17M | -8.09M |
Interest Income | 1.41M | 1.13M | 843K | 826K | 935K | 998K | 1.14M | 1.18M | 1.21M | 1.22M | 1.12M | 424K | 195K | 4K | 3K | 2K | 2K | 3K |
Pretax Income | -12.32M | -10.35M | -11.4M | -13.27M | -12.36M | -10.91M | -7.8M | -7.71M | -7.17M | -6.41M | -5.52M | -8.27M | -8.06M | -7.33M | -8.53M | -7.25M | -9.8M | -8.39M |
Net Income | -12.3M | -10.34M | -11.41M | -13.24M | -12.35M | -10.9M | -7.82M | -7.7M | -7.14M | -6.4M | -5.5M | -8.27M | -8.05M | -7.33M | -8.52M | -7.25M | -9.79M | -8.37M |
Selling & General & Admin | 4.33M | 3.66M | 2.92M | 2.86M | 3.23M | 3.07M | 2.38M | 2.72M | 2.54M | 2.56M | 2.34M | 2.64M | 2.72M | 2.38M | 2.09M | 2.23M | 2.67M | 2.5M |
Research & Development | 9.39M | 7.81M | 9.33M | 11.22M | 10.02M | 8.8M | 6.52M | 6.32M | 5.84M | 5M | 4.32M | 5.77M | 5.1M | 4.64M | 6.18M | 4.72M | 6.5M | 5.59M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 13.72M | 11.47M | 12.24M | 14.09M | 13.25M | 11.87M | 8.9M | 9.04M | 8.38M | 7.56M | 6.66M | 8.4M | 7.82M | 7.03M | 8.27M | 6.95M | 9.17M | 8.09M |
Interest Expense | n/a | n/a | 1K | 1K | 1K | 1K | 4K | 3K | 151K | 231K | 274K | 292K | 295K | 302K | 309K | 303K | 296K | 294K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -38K | -35K | -35K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 13.72M | 11.47M | 12.24M | 14.09M | 13.29M | 11.91M | 8.93M | 9.04M | 8.38M | 7.56M | 6.66M | 8.4M | 7.82M | 7.03M | 8.27M | 6.95M | 9.17M | 8.09M |
Income Tax Expense | -21K | -11K | 16K | -31K | -8K | -8K | 18K | -13K | -30K | -7K | -20K | -7K | -4K | -5K | -6K | 2K | -2K | -15K |
Shares Outstanding (Basic) | 130.35M | 117.61M | 106.01M | 101.04M | 101.04M | 99.52M | 99.49M | 99.33M | 98.7M | 98.61M | 98.13M | 68.9M | 59.54M | 30.81M | 21.61M | 21.61M | 20.12M | 19.42M |
Shares Outstanding (Diluted) | 130.35M | 117.61M | 106.01M | 101.04M | 101.04M | 99.52M | 99.49M | 99.33M | 98.7M | 98.61M | 98.13M | 68.9M | 59.54M | 30.81M | 21.61M | 21.61M | 20.12M | 19.42M |
EPS (Basic) | -0.09 | -0.09 | -0.11 | -0.13 | -0.12 | -0.11 | -0.08 | -0.08 | -0.07 | -0.06 | -0.06 | -0.12 | -0.14 | -0.24 | -0.39 | -0.34 | -0.49 | -0.43 |
EPS (Diluted) | -0.09 | -0.09 | -0.11 | -0.13 | -0.12 | -0.11 | -0.08 | -0.08 | -0.07 | -0.06 | -0.06 | -0.12 | -0.14 | -0.24 | -0.39 | -0.34 | -0.49 | -0.43 |
EBITDA | -13.72M | -11.47M | -11.36M | -13.24M | -12.32M | -10.87M | -7.76M | -7.67M | -6.99M | -6.16M | -5.24M | -7.97M | -7.75M | -7.02M | -8.21M | -6.94M | -9.49M | -8.08M |
EBIT | -12.32M | -10.35M | -11.4M | -13.27M | -12.36M | -10.91M | -7.8M | -7.71M | -7.02M | -6.18M | -5.25M | -7.98M | -7.76M | -7.03M | -8.22M | -6.95M | -9.5M | -8.09M |
Depreciation & Amortization | n/a | 37K | 38K | 36K | 38K | 35K | 35K | 35K | 34K | 19K | 15K | 9K | 8K | 11K | 12K | 13K | 12K | 13K |